| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $3.2M | -41.5% | -47.8% |
| SG&A Expense | $4.0M | -19.3% | -28.3% |
| Operating Income | -$7.3M | +30.9% | +38.5% |
| Interest Expense | $725K | -17.3% | -45.8% |
| Net Income | -$5.4M | +19.1% | +20.2% |
| EPS (Basic) | -$0.12 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.1M | -59.4% | -3.1% |
| Current Assets | $5.0M | -55.3% | -84.7% |
| Total Assets | $10.1M | -40.0% | -76.7% |
| Current Liabilities | $19.1M | -7.2% | -5.3% |
| Long-term Debt | $13.8M | -21.4% | -52.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.0M | — | — |
| Capital Expenditures | $88K | — | — |
| Investing Cash Flow | $23.9M | — | — |
| Financing Cash Flow | -$4.6M | — | — |
| Free Cash Flow | -$19.1M | — | — |
| +50.0% |
| EPS (Diluted) | -$0.12 | +33.3% | +50.0% |
| $22.1M |
| -15.1% |
| -41.4% |
| Stockholders' Equity | -$7.9M | -41.0% | -351.9% |